Login / Signup

Malignant meningioma mTOR mutated and precision medicine.

Veronica VillaniAntonio TanzilliAntonello VidiriFelice GiangasperoGennaro CilibertoAlessandro OliviAndrea Pace
Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2022)
This case report provides evidence on the efficacy of mTOR inhibitors as a treatment option in recurrent meningiomas. Furthermore, it highlights the importance of performing a molecular analysis as a preliminary step towards targeting the mTOR pathway.
Keyphrases
  • case report
  • cell proliferation
  • cancer therapy
  • drug delivery